Facilitators and barriers to reducing chemotherapy for early-stage breast cancer: a qualitative analysis of interviews with patients and patient advocates

BACKGROUND: As the combination of systemic and targeted chemotherapies is associated with severe adverse side effects and long-term health complications, there is interest in reducing treatment intensity for patients with early-stage breast cancer (EBC). Clinical trials are needed to determine the f...

Descripción completa

Detalles Bibliográficos
Autores principales: Andrews, Courtney, Childers, Timothy C., Wiseman, Kimberly D., Lawhon, Valerie, Ingram, Stacey, Smith, Mary Lou, Wolff, Antonio C., Wagner, Lynne, Rocque, Gabrielle B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8815019/
https://www.ncbi.nlm.nih.gov/pubmed/35120494
http://dx.doi.org/10.1186/s12885-022-09189-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8815019/
https://www.ncbi.nlm.nih.gov/pubmed/35120494
http://dx.doi.org/10.1186/s12885-022-09189-w

Ejemplares similares